A large prospective multicentre study by Thomusch et al
Leipziger today
Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity
Current GLP-1RA treatments will also likely retain their patents into the 2030s, reducing competition and preventing consumers from driving down prices
22 , 21762189, doi: 10.1210/me.2008-0023 (2008)
Medication In rats with suprahepatic occlusion of the inferior vena cava, in evaluating lesions and blood vessels by gross and microscopic assessment, electrocardiogram (ECG), thrombosis, serum enzyme levels and oxidative stress (MDA and nitric oxide, NO levels) in liver tissue, rats were treated with 10 g/kg BPC 157, 10 ng/kg BPC 157, or 5mL/kg saline as an abdominal bath at 1 min ligation-time